AchieveCE HIV – 40 Years And Counting…
With eight categories of HIV meds now available, healthcare professionals need to be up to date about these therapies. Whether using regimens from 20 years ago, or the newest drugs healthcare professionals need to be monitoring adherence to those regimens. By providing data from the San Francisco Study to show the needs for 95% adherence. This Florida-approved course will also describe the advantages and disadvantages of each category of drugs, as well as those individual drugs.
Cost: $15.00Add to cart
-Video-based Learning – Downloadable Handout -Desktop, Mobile, and Tablet friendly. -Self-Paced Learning -No Time Limits or Expiration -Includes an evaluation and assessment -Downloadable Certificate -Credits are reported to CE Broker and/or CPE automatically within 24 hours
Modes of Transmission of HIV Monitoring Antiretroviral Therapy (ART) Frequency of Measurements When to Start HIV Therapy? Why Start So Soon? AIDS- Defining Illnesses Getting Patients on board with therapy 1987: The first approved treatment for HIV -Nucleoside reverse transcriptase inhibitors 1995: Protease Inhibitors Introduced -Protease Inhibitors 1996: Non-Nucleoside Reverse Transcriptase Inhibitors Enters -Cross Over Resistance -New mechanisms of action lead to drop in death rates 2003: Attachment inhibitor introduced 2007: Chemokine Receptor Antagonist Introduced 2007: Integrase Strand Inhibitors INSTI -Most INSTI come as combo products 2018: Every disease needs a monoclonal antibody! 2020: Gp210 – directed attachment inhibitor 2021: Cabotegravir / rilpivirine (Cabenuva) -Cabotegravir / rilpivirine (Cabenuva) Dosing Why PrEP? -More on PrEP PEP for Exposed Health Care Workers Healthcare Worker to Patient Transmission It isn’t just about the HIV drugs Other Vaccines? Depends on CD4 count Pregnancy and HIV Treatment for pregnant patients Treatment for the Neonate Standard Precautions Types of PPE in Healthcare Settings Key Points about PPE Florida – here’s what needs covered Florida – It’s the LAW References
At the conclusion of this continuing education activity, the participant will be able to: 1. Define HIV and AIDS, its history and epidemiology 2. Identify common modes of HIV transmission 3. Describe methods in which HIV may be transmitted in a healthcare setting 4. Discuss universal precautions and other infection control techniques that can reduce the risk of HIV transmission in healthcare settings 5. Identify common secondary infections and conditions associated with HIV and AIDS 6. Determine clinical strategies for the prevention and management of HIV and AIDS and describe the changes in HIV disease state management over the past 40 years 7. Discuss federal and Florida laws pertaining to HIV and AIDS, including confidentiality of testing, the treatment of patients, partner notification and reporting requirements, and the offering of HIV testing to pregnant women
Dental Professional Nurse Pharmacist Pharmacy Technician Physician Physician Assistant
Additional credit info
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Continuing Education Company, Inc. and AchieveCE. Continuing Education Company, Inc. is accredited by the ACCME to provide continuing medical education for physicians. Continuing Education Company, Inc. designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AchieveCE is also accredited by the Florida Board of Pharmacy (provider no. 50-20641). This course is approved by CE Broker, with CE Broker No. 20-869919. Universal Activity Number: Pharmacist: 0657-0000-21-163-H02-P Pharmacy Technician: 0657-0000-21-163-H02-T AchieveCE is an approved provider of nursing continuing professional development by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. GNA Approved Provider Number is 4003268. Start Date: 07/14/2022 Expiration Date: 01/14/2023 AchieveCE’s dental CE courses are accredited through the Academy of General Dentistry (AGD) with provider ID #386503.